These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7695439)
1. [Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice]. Pasiukov VV; Ryzhko IV; Tsuraeva RI; Samokhodkina ED; Roshchina NV Antibiot Khimioter; 1994 Aug; 39(8):37-40. PubMed ID: 7695439 [TBL] [Abstract][Full Text] [Related]
2. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice]. Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316 [TBL] [Abstract][Full Text] [Related]
3. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1]. Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699 [TBL] [Abstract][Full Text] [Related]
4. [Ceftriaxone in prevention and treatment of experimental plague infection]. Ryzhko IV; Samokhodkina ED; Zhigalova TA Antibiot Khimioter; 1993 Jan; 38(1):39-42. PubMed ID: 8060183 [TBL] [Abstract][Full Text] [Related]
5. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen]. Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe]. Ryzhko IV; Shcherbaniuk AI; Moldavan IA; Tsuraeva RI; Anisimov BI; Trishina AV Antibiot Khimioter; 2007; 52(9-10):24-7. PubMed ID: 20583467 [TBL] [Abstract][Full Text] [Related]
7. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment]. Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117 [TBL] [Abstract][Full Text] [Related]
8. [Doxycycline in the prevention of experimental plague induced by plague microbe variants]. Samokhodkina ED; Ryzhko IV; Shcherbaniuk AI; Kasatkina IV; Tsuraeva RI; Zhigalova TA Antibiot Khimioter; 1992 Nov; 37(11):26-8. PubMed ID: 1300930 [TBL] [Abstract][Full Text] [Related]
9. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe]. Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907 [TBL] [Abstract][Full Text] [Related]
10. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen]. Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704 [TBL] [Abstract][Full Text] [Related]
11. [Efficacy of rifampicin in experimental plague infection]. Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275 [TBL] [Abstract][Full Text] [Related]
12. [Synergistic action of some antibacterial agents in studies on albino mice with experimental plague caused by Fr- phenotype strain of the plague microbe]. Shcherbaniuk AI; Liukshina EIu; Ryzhko IV; Smorodinova IuV Antibiot Khimioter; 2006; 51(1):7-10. PubMed ID: 16734358 [TBL] [Abstract][Full Text] [Related]
13. [Primary characterization of the properties and diagnostic value of the antigenic complex "fraction V" in a plague microbe]. Bozhko NV; Lebedeva SA; Bichul' OK; Ivanova VS; Lysova LK; Barabash GP; Nekliaev VN; trukhachev AL; Terent'ev AN Klin Lab Diagn; 2005 Jun; (6):45-9. PubMed ID: 16078534 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478 [TBL] [Abstract][Full Text] [Related]
15. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague]. Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325 [TBL] [Abstract][Full Text] [Related]
16. [Chromosomal resistance of plague agent to quinolones]. Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573 [TBL] [Abstract][Full Text] [Related]
17. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))]. Ryzhko IV; Trishina AV; Verkina LM Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421 [TBL] [Abstract][Full Text] [Related]
18. [Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra- phenotypes]. Ryzhko IV; Shcherbaniuk AI; Samokhodkina ED; Tsuraeva RI; Mishn'kin BN; Kasatkina IV; Zhigalova TA Antibiot Khimioter; 1994 Apr; 39(4):32-6. PubMed ID: 7826172 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain]. Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]